BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19444722)

  • 1. Supervised methadone consumption: client issues and stigma.
    Anstice S; Strike CJ; Brands B
    Subst Use Misuse; 2009; 44(6):794-808. PubMed ID: 19444722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone maintenance treatment for youth: experiences of clients, staff, and parents.
    Guarino HM; Marsch LA; Campbell WS; Gargano SP; Haller DL; Solhkhah R
    Subst Use Misuse; 2009; 44(14):1979-89. PubMed ID: 20001689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of methadone dispensing in Belgium--study synopsis].
    Ledoux Y
    J Pharm Belg; 2004; 59(3):69-79. PubMed ID: 15553322
    [No Abstract]   [Full Text] [Related]  

  • 4. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
    Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
    Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is low threshold methadone maintenance treatment?
    Strike C; Millson M; Hopkins S; Smith C
    Int J Drug Policy; 2013 Nov; 24(6):e51-6. PubMed ID: 23743178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of first 8 pilot methadone maintenance treatment clinics in China].
    Pang L; Mi GD; Wang CH; Luo W; Rou KM; Li JH; Wu ZY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):2-4. PubMed ID: 17429519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response phases in methadone treatment for chronic nonmalignant pain.
    Arnaert A; Ciccotosto G
    Pain Manag Nurs; 2006 Mar; 7(1):23-30. PubMed ID: 16490733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to, and incentives for, the transfer of opioid-dependent people on methadone maintenance treatment from secondary care to primary health care.
    Sheridan J; Goodyear-Smith F; Butler R; Wheeler A; Gohns A
    Drug Alcohol Rev; 2008 Mar; 27(2):178-84. PubMed ID: 18264879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone as social control: institutionalized stigma and the prospect of recovery.
    Harris J; McElrath K
    Qual Health Res; 2012 Jun; 22(6):810-24. PubMed ID: 22232295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone maintenance treatment: outcomes from the Otago methadone programme.
    Dore GM; Walker JD; Paice JR; Clarkson S
    N Z Med J; 1999 Nov; 112(1100):442-5. PubMed ID: 10678242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland's drug and alcohol services.
    Moran L; Keenan E; Elmusharaf K
    BMC Health Serv Res; 2018 Nov; 18(1):911. PubMed ID: 30497467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors influencing the rate on retention to methadone maintenance treatment program among heroin addicts in Guizhou, China].
    Liang T; Liu EW; Zhong H; Wang B; Shen LM; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):131-5. PubMed ID: 19565871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of illegal opioid use and health services utilization in Canada.
    Popova S; Rehm J; Fischer B
    Public Health; 2006 Apr; 120(4):320-8. PubMed ID: 16476455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to methadone maintenance treatment of opiate dependent patients with and without significant pain.
    Ilgen MA; Trafton JA; Humphreys K
    Drug Alcohol Depend; 2006 May; 82(3):187-93. PubMed ID: 16219429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The making of the chronic addict.
    Järvinen M; Andersen D
    Subst Use Misuse; 2009; 44(6):865-85. PubMed ID: 19444727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug addiction from a psychodynamic perspective: methadone maintenance treatment (MMT) as transitional phenomena.
    Potik D; Adelson M; Schreiber S
    Psychol Psychother; 2007 Jun; 80(Pt 2):311-25. PubMed ID: 17535602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agency and dependency within treatment: drug treatment clients negotiating methadone and antidepressants.
    Holt M
    Soc Sci Med; 2007 May; 64(9):1937-47. PubMed ID: 17321658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.